Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04439630
Other study ID # Protokoll 2018/8-b
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2020
Est. completion date August 1, 2020

Study information

Verified date October 2020
Source Lund University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postprandial effects of Nopal fractions on glucose and appetite regulation will be investigated in healthy humans, in a randomised controlled crossover trial


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date August 1, 2020
Est. primary completion date August 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy

- non-smokers

- diet accordance with the Nordic Nutrition Recommendations

- BMI: 18.5-25 kg/m2

Exclusion Criteria:

- metabolic disorders

- food allergies

- no probiotics or other food /supplement which may interfere with the study

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nopal fractions
Nopal flour were divided in two fractions and mixed in two different test breads
Test product without the active components
Test product without the active components

Locations

Country Name City State
Sweden Food Technology, engineering and Nutrition, LTH, Lund University Lund

Sponsors (1)

Lead Sponsor Collaborator
Lund University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary postprandial glucose tolerance effects on postprandial glucose tolerance after intake of test products at breakfast. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min. 0-180 min after start of the meal
Primary postprandial insulin concentrations effects on serum insulin concentrations after intake of test products at breakfast. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min. 0-180 min
Secondary subjective appetite variables Subjective appetite variables (hunger, satiety, desire to eat) after intake of test products at breakfast, using a 100 mm Visual Analogue Scale (VAS) on a white paper. Except from a center mark in the center of the scale there was no other visible marks. Measurements were performed at fasting (time = 0 min) and at 15, 30, 45, 60, 90, 120, 150 and 180 min. 0-180 min
See also
  Status Clinical Trial Phase
Completed NCT02913079 - The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels N/A
Completed NCT02065271 - Herbal Preparation and Glucose Homeostasis N/A
Completed NCT00985270 - Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis Phase 4
Completed NCT01705639 - Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene Phase 3
Active, not recruiting NCT01798030 - Vitamin D Retrospective Study and Role With Disease
Completed NCT03423381 - Dietary Fibre and Metabolic Benefits N/A
Completed NCT06193291 - Effect of Hot Water Immersion on Heart Rate Variability and Glucose N/A
Recruiting NCT05300256 - Peripheral Heating and Glucose Tolerance N/A
Completed NCT03714438 - Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults Phase 2
Completed NCT00628524 - Homburg Cream & Sugar Study N/A
Recruiting NCT03725969 - Effect of Camel Milk on Insulin and Incretin Response N/A
Completed NCT03872557 - Modulating Glucose Tolerance With Dietary Tyrosine N/A
Recruiting NCT04966299 - Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents N/A
Completed NCT04904133 - Effects of Low/No Calorie Sweeteners on Glucose Tolerance N/A